Case Reports in Hepatology (Jan 2020)

A Case of Drug-Induced Liver Injury Secondary to Natalizumab

  • Phillip P. Santoiemma,
  • Haripriya Maddur,
  • Christopher M. Moore

DOI
https://doi.org/10.1155/2020/7976585
Journal volume & issue
Vol. 2020

Abstract

Read online

A 33-year-old Caucasian female with relapsing-remitting multiple sclerosis presented with abdominal pain, nausea, and vomiting and was found to have acute liver injury. After thorough investigation, she was diagnosed with drug-induced liver injury (DILI) thought secondary to redosing of Natalizumab therapy.